Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
Allspring Global Investments Holdings LLC’s holdings in Maravai LifeSciences were worth $2,071,000 as of its most recent filing with the SEC.
Credit Suisse AG’s holdings in Maravai LifeSciences were worth $2,792,000 at the end of the most recent reporting period.
Finally, Robert W. Baird cut their target price on shares of Maravai LifeSciences from $18.00 to $11.00 and set an “outperform” rating on the stock in a research note on Tuesday, August 8th.
Finally, Steward Partners Investment Advisory LLC boosted its position in Maravai LifeSciences by 6,670.0% during the second quarter.
Harbor Capital Advisors Inc. purchased a new stake in Maravai LifeSciences Holdings, Inc. () during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).
Maravai LifeSciences Holdings, Inc. has a 1 year low of $12.16 and a 1 year high of $36.17.
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Holdings Lifted by Federated Hermes Inc.
Maravai LifeSciences () last released its quarterly earnings results on Monday, August 7th.
We look forward to a successful 2023, and setting the stage for a return to overall growth with an increasingly valuable Maravai heading into 2024.